| | Variable | MVI Negative | MVI Positive | T/ | P value | | (n=32) | (n=28) |
| | Age, y | 53.9±12.9 | 49.1±12.1 | 1.489 | 0.142 | | Gender (male, female) | 28/4 | 22/6 | 0.335 | 0.563 | | BMI, Kg/m2 | 22.7±3.9 | 22.8±3.5 | -0.056 | 0.955 | | PLT,/L | 165.1±99.9 | 231.1±174.9 | -1.825 | 0.073 | | ALB, g/L | 41.2±5.5 | 40.1±6.5 | 0.771 | 0.444 | | TB, umol/L | 20.2±29.4 | 15.5±8.0 | 0.818 | 0.417 | | ALT, U/L | 57.4±70.4 | 63.0±85.4 | -0.278 | 0.782 | | AST, U/L | 45.5±46.0 | 85.5±131.5 | -1.615 | 0.112 | | GGT, U/L | 102.6±242.6 | 113.8±119.0 | -0.223 | 0.824 | | PT, S | 13.8±1.2 | 13.4±0.8 | 1.503 | 0.138 | | PTA, % | 91.8±14.1 | 95.6±11.1 | -1.156 | 0.253 | | Liver Function Grading (A/B) | 30/2 | 28/0 | - - - | 0.494 | | HBV DNA(<10e3, ≥ 10e3IU/mL) | 28/4 | 18/10 | 4.499 | 0.034 | | AFP(≤400,>400ng/ml) | 25/7 | 20/8 | 0.357 | 0.550 | | HCV (Absent, Present) | 31/1 | 28/0 | - - - | 1.000 | | Tumor size, cm | 4.3±2.7 | 7.9±4.1 | -3.940 | <0.001 | | CT value in unenhanced phase (≤42.5,>42.5) | 17/15 | 11/17 | 1.149 | 0.284 | | CT value in artery phase(≤66.5,>66.5) | 12/20 | 8/20 | 0.536 | 0.464 | | CT value in venous phase(≤102,>102) | 27/5 | 17/11 | 4.275 | 0.039 | | CT value in delayed phase(≤103.5,>103.5) | 31/1 | 20/8 | 5.720 | 0.017 | | Located in the left lobe (Absent, Present) | 24/8 | 20/8 | 0.097 | 0.755 | | Capsule (Absent, Present) | 24/8 | 20/8 | 0.097 | 0.755 | | With smooth margin (Absent, Present) | 26/6 | 25/3 | 0.257 | 0.612 | | Peritumoral enhancement (Absent, Present) | 29/3 | 18/10 | 6.104 | 0.013 | | Visible small blood vessel (Absent, Present) | 17/15 | 4/24 | 9.902 | 0.002 | | The distance from the IVC | 4.0±2.4 | 2.3±1.9 | 3.001 | 0.004 | | The distance from the portal vein branches | 4.0±1.8 | 3.0±2.3 | 1.870 | 0.067 | | Liver cirrhosis (Absent, Present) | 17/15 | 18/10 | 0.765 | 0.382 |
|
|
